» Articles » PMID: 26143628

Sphincter of Oddi Dysfunction: Updates from the Recent Literature

Overview
Specialty Gastroenterology
Date 2015 Jul 6
PMID 26143628
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Sphincter of Oddi dysfunction (SOD) has long been a controversial topic, starting with whether it even exists, as a sphincterotomy-responsive entity to treat, for either: (1) post-cholecystectomy abdominal pain and/or (2) idiopathic recurrent acute pancreatitis (IRAP). Many of its aspects had required further research to better prove or refute its existence and to provide proper recommendations for physicians to diagnose and treat this condition. Fortunately, there has been major advancement in our knowledge in several areas over the past few years. New studies on challenging the classification, exploring alternative diagnostic methods, and quantifying the role of sphincterotomy in treatment of SOD for post-cholecystectomy pain and for IRAP were recently published, including a randomized trial in each of the two areas. The goal of this paper is to review recent literature on selected important questions and to summarize the results of major trials in this field.

Citing Articles

Biliary Dyskinesia with Reduced Gallbladder Ejection Fraction: A Diagnostic and Therapeutic Shift in Management.

Elaskandrany M, Ismail M, Liu Y, Wang W J Brown Hosp Med. 2025; 4(1):6-9.

PMID: 40027459 PMC: 11864417. DOI: 10.56305/001c.127836.


Turkish Society of Gastroenterology: Pancreas Working Group, Acute Pancreatitis Committee Consensus Report.

Ogutmen Koc D, Bengi G, Gul O, Ozen Alahdab Y, Altintas E, Barutcu S Turk J Gastroenterol. 2024; 35(Suppl 1):S1-S44.

PMID: 39599919 PMC: 11670795. DOI: 10.5152/tjg.2024.24392.


Dysfunction of Biliary Sphincter of Oddi-Clinical, Diagnostic and Treatment Challenges.

Kegnaes M, Novovic S, Shabanzadeh D J Clin Med. 2023; 12(14).

PMID: 37510917 PMC: 10381482. DOI: 10.3390/jcm12144802.


Safety of Eluxadoline in Patients with Irritable Bowel Syndrome with Diarrhea.

Cash B, Lacy B, Schoenfeld P, Dove L, Covington P Am J Gastroenterol. 2016; 112(2):365-374.

PMID: 27922029 PMC: 5318664. DOI: 10.1038/ajg.2016.542.


How to apply clinical cases and medical literature in the framework of a modified "failure mode and effects analysis" as a clinical reasoning tool--an illustration using the human biliary system.

Wong K J Med Case Rep. 2016; 10:85.

PMID: 27048215 PMC: 4822271. DOI: 10.1186/s13256-016-0850-6.

References
1.
Kalaitzakis E, Ambrose T, Phillips-Hughes J, Collier J, Chapman R . Management of patients with biliary sphincter of Oddi disorder without sphincter of Oddi manometry. BMC Gastroenterol. 2010; 10:124. PMC: 2975654. DOI: 10.1186/1471-230X-10-124. View

2.
Durkalski V, Stewart W, MacDougall P, Mauldin P, Romagnuolo J, Brawman-Minzter O . Measuring episodic abdominal pain and disability in suspected sphincter of Oddi dysfunction. World J Gastroenterol. 2010; 16(35):4416-21. PMC: 2941064. DOI: 10.3748/wjg.v16.i35.4416. View

3.
Varadarajulu S, Hawes R, Cotton P . Determination of sphincter of Oddi dysfunction in patients with prior normal manometry. Gastrointest Endosc. 2003; 58(3):341-4. DOI: 10.1067/s0016-5107(03)00005-1. View

4.
Murray W . Botulinum toxin-induced relaxation of the sphincter of Oddi may select patients with acalculous biliary pain who will benefit from cholecystectomy. Surg Endosc. 2010; 25(3):813-6. DOI: 10.1007/s00464-010-1260-2. View

5.
GEENEN J, Hogan W, Dodds W, STEWART E, Arndorfer R . Intraluminal pressure recording from the human sphincter of Oddi. Gastroenterology. 1980; 78(2):317-24. View